Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motolimod plus cyclophosphamide in advanced solid tumors
NCT02650635Phase 1Terminated
- Sponsor
- Mayo Clinic
- Start
- Feb 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of motolimod in Solid neoplasm, pancreatic adenocarcinoma (PDAC), breast cancer and 4 more, sponsored by Mayo Clinic. Started Feb 2016; status: terminated.
02
Drugs
motolimod
03
Conditions
Solid neoplasmpancreatic adenocarcinoma (PDAC)breast cancermelanomarenal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT02650635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02650635.